Literature DB >> 30234387

Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma.

Emanuele Cencini1, Alberto Fabbri1, Luana Schiattone1, Monica Bocchia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30234387     DOI： 10.1080/10428194.2018.1504938

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine: A case report.

Authors:  Zhencang Zhou; Pengqiang Wu; Fujue Wang; Huan Tao; Yingying Chen; Jie Gao; Dengke Chen; Yongqian Jia
Journal:  Medicine (Baltimore)       Date:  2022-03-04       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.